This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Why economic indicators matter to investors: indicators help assess health, predict trends, and guide decisions, improving timing and risk management.
27,651 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Delve into the investing philosophy of Bill Miller IV, the CIO and PM behind Miller Value Fund. Learn how high-convic...
A major hedge fund just sold its entire Abercrombie & Fitch stake. Here’s what that means for investors, how to inter...
A new breed of trading platform promises 24/7 tokenized stock access and self-clearing tech. This deep dive explains ...
As SpaceX moves toward a historic public listing, Antonio Gracias could see his private stake surge into the tens of ...
A notable investor doubled down on XPLR Infrastructure after a sharp 42% rise, highlighting the appeal of long-term, ...
Chipotle stock rallied today after a major bank upgraded the stock and signaling confidence in its growth plan. This ...
The AI rally cooled as major chip makers like NVIDIA, Intel, and Marvell pulled back. This article breaks down why th...
AI-driven demand pushed Intel, AMD, Arm and other AI stocks higher today. Learn what drove the rally, what it means f...
Micron Technology has sprinted to the high end of a price landscape after surging 814% year. As investors weigh the n...
New hiring data arrives as investors weigh whether layoffs to boost efficiency undermine long-term growth. Experts wa...
Palantir shares slip in a broad software selloff, brushing near key support as investors weigh growth prospects again...